Biofilm culture of Pseudomonas aeruginosa expressing lux genes as a model to study susceptibility to antimicrobials.

A simple in vitro model for culture of biofilm populations of self-bioluminescent Pseudomonas aeruginosa was used for real-time monitoring of the effects of ciprofloxacin. Biofilms of these organisms were established within Sorbarod filters, perfused with a chemically defined simple salts medium. The biofilm population was shown to achieve a pseudo-steady state which was reproducible and stable over several days. The viability of membrane-associated and eluted cells was assessed by spread plate viable counts and by monitoring bioluminescence as a measure of metabolic activity. Pseudo-steady state biofilms were exposed to 5x MIC ciprofloxacin (0.3 mg x l(-1)) in the perfusing medium for 1 h. Whilst both methods for viability assessment indicated an immediate reduction in viable cell numbers, the decline recorded with bioluminescence was greater. The use of bioluminescent bacteria proved to be a rapid and sensitive method for the measurement of real-time antibacterial effects on a bacterial biofilm.

[1]  K. Bowker,et al.  Use of a clinical Escherichia coli isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxifloxacin. , 1999, The Journal of antimicrobial chemotherapy.

[2]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[3]  Mohamed O. Elasri,et al.  Study of the Response of a Biofilm Bacterial Community to UV Radiation , 1999, Applied and Environmental Microbiology.

[4]  G. Junter,et al.  Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin. , 1998, The Journal of antimicrobial chemotherapy.

[5]  K. Bowker,et al.  Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans. , 1998, Journal of Antimicrobial Chemotherapy.

[6]  M. Karp,et al.  Generation of Bioluminescent Streptococcus mutans and Its Usage in Rapid Analysis of the Efficacy of Antimicrobial Compounds , 1998, Antimicrobial Agents and Chemotherapy.

[7]  Tsuyoshi Otani,et al.  In Vitro and In Vivo Activities of Levofloxacin against Biofilm-Producing Pseudomonas aeruginosa , 1998, Antimicrobial Agents and Chemotherapy.

[8]  J. Costerton,et al.  The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.

[9]  P. Stewart,et al.  Theoretical aspects of antibiotic diffusion into microbial biofilms , 1996, Antimicrobial agents and chemotherapy.

[10]  D. Roop,et al.  Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. , 1995, Gene.

[11]  M. R. Brown,et al.  A simple in vitro model for growth control of bacterial biofilms. , 1995, The Journal of applied bacteriology.

[12]  F. Marincs,et al.  Immobilization of Escherichia coli expressing the lux genes of Xenorhabdus luminescens , 1994, Applied and environmental microbiology.

[13]  M. R. Brown,et al.  Sensitivity of biofilms to antimicrobial agents. , 1993, The Journal of applied bacteriology.

[14]  D. Stickler.  Biofilms : Ecology and industrial microbiology , 1999 .

[15]  T. Maira-Litrán,et al.  Perfused biofilm fermenters. , 1999, Methods in enzymology.

[16]  D. Greenwood,et al.  A GUIDE TO SENSITIVITY TESTING , 1991 .

[17]  D. Wilbur,et al.  An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage. , 1991, The Journal of antimicrobial chemotherapy.

[18]  R. Cox,et al.  Amantadine prophylaxis for health care workers: unanswered questions. , 1991 .